Jain Nikunj 4

What Happened
Nikunj Jain, Principal Accounting Officer of Sangamo Therapeutics (SGMO), surrendered 7,721 shares on January 22, 2026 to satisfy mandatory tax withholding tied to an RSU vesting. The transaction is reported as a disposition (code F) and used the issuer's closing price on 1/22/2026 of $0.3985/share (reported per-share amount $0.40), representing roughly $3,077 remitted to the company. This was a withholding sale to the issuer, not an open-market sale.

Key Details

• Transaction date: January 22, 2026; Form 4 filed January 26, 2026 (timely within the two-business-day rule).
• Shares surrendered: 7,721; per-share price used: $0.3985 (closing price), reported as $0.40; total value ≈ $3,077.
• Net from the vested installment: 11,029 RSU shares vested on Jan 22, 2026; after surrendering 7,721 for taxes, 3,308 of those vested shares remained issued to the reporting person.
• Footnotes: (F1) confirms the shares were surrendered solely for mandatory tax withholding (not a discretionary sale); (F2) details other RSU grants and vesting schedules (1,618 shares from a 2023 grant and 49,726 from a 2025 grant, subject to future vesting and continuous service); (F3) notes the reporting person holds 5,000 shares from the 2020 Employee Stock Purchase Plan.
• Transaction code meaning: F = tax withholding (disposition to issuer).

Context
This is a routine tax-withholding disposition tied to RSU vesting and should not be read as a market-timing sale. Such transactions are administrative: shares are surrendered to the issuer to cover tax obligations rather than sold in the open market.